|
Volumn 118, Issue 4, 2002, Pages 1128-1131
|
Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype
|
Author keywords
Acute myelogeneous leukaemia; Allogeneic haploidentical stem cell transplantation; CD34 cell isolation; Engraftment; Mesenchymal stem cell
|
Indexed keywords
CD34 ANTIGEN;
CYTARABINE;
ETOPOSIDE;
IDARUBICIN;
MITOXANTRONE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
ARTICLE;
CANCER ADJUVANT THERAPY;
CANCER RADIOTHERAPY;
CASE REPORT;
CONTROLLED STUDY;
DISEASE COURSE;
FEMALE;
GRAFT VERSUS HOST REACTION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HLA MATCHING;
HUMAN;
MESENCHYME CELL;
PRIORITY JOURNAL;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ADULT;
BONE MARROW TRANSPLANTATION;
FEMALE;
GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT;
HEMATOPOIETIC STEM CELL MOBILIZATION;
HISTOCOMPATIBILITY TESTING;
HUMANS;
LEUKEMIA, MYELOCYTIC, ACUTE;
LYMPHOCYTE DEPLETION;
MALE;
MESODERM;
STEM CELL TRANSPLANTATION;
T-LYMPHOCYTES;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 0036050976
PISSN: 00071048
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2141.2002.03767.x Document Type: Article |
Times cited : (133)
|
References (12)
|